Led by Dr. Ryotaro Hashizume of the Graduate School of Medicine, Unit for Genomic Manipulation and Technology Development, the team had successfully developed a technique to eliminate the extra copy of chromosome 21 in cells derived from individuals with Down syndrome. The condition, caused by trisomy 21, affects roughly one in every 700 births and leads to intellectual disabilities and other health complications.